Correlation Between Monte Rosa and Trevena

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Trevena at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Trevena into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Trevena, you can compare the effects of market volatilities on Monte Rosa and Trevena and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Trevena. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Trevena.

Diversification Opportunities for Monte Rosa and Trevena

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monte and Trevena is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Trevena in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevena and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Trevena. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevena has no effect on the direction of Monte Rosa i.e., Monte Rosa and Trevena go up and down completely randomly.

Pair Corralation between Monte Rosa and Trevena

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 0.7 times more return on investment than Trevena. However, Monte Rosa Therapeutics is 1.43 times less risky than Trevena. It trades about 0.11 of its potential returns per unit of risk. Trevena is currently generating about -0.03 per unit of risk. If you would invest  582.00  in Monte Rosa Therapeutics on September 3, 2024 and sell it today you would earn a total of  454.00  from holding Monte Rosa Therapeutics or generate 78.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy48.44%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Trevena

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Trevena 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trevena has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Monte Rosa and Trevena Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Trevena

The main advantage of trading using opposite Monte Rosa and Trevena positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Trevena can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevena will offset losses from the drop in Trevena's long position.
The idea behind Monte Rosa Therapeutics and Trevena pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets